UNIVERSITE PARIS 12 - VAL DE MARNE;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);ELRO PHARMA
发明人:
ZIMMER, ROBERT,COURTY, JOSE
申请号：
CA2813665
公开号：
CA2813665A1
申请日:
2011.10.04
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The present invention relates to a composition comprising a Nucant multivalent synthetic compound and a glycosaminoglycan, the admixture of both compounds forming microspheres comprising both compounds, as well as their use for the treatment or prevention of diseases associated to deregulation of proliferation and/or angiogenesis, such as cancer, inflammatory disease, or for promoting wound healing
